zPREDICTA YC Application
zPREDICTA went through Y Combinator in the Summer 2015 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2015
- Industry
- HealthcareDrug Discovery and Delivery
- Team size
- 2
- Status
- Acquired
- Launched
- 2015
Founders
Mukti ParikhFounder/CTO
What zPREDICTA does
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.
zPREDICTA's YC application, reconstructed
Y Combinator application
zPREDICTA, Summer 2015 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
zPREDICTA
Patient-derived 3D tissue models for drug testing
We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.
We live in San Jose, CA, and plan to keep the company based here after YC.
San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real zPREDICTA YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from zPREDICTA's public data (launch notes, founder backgrounds, product description). It shows how a company like zPREDICTA would present itself to YC, not the text they submitted.
What YC batch was zPREDICTA in?
zPREDICTA was part of the Y Combinator Summer 2015 batch.
Who founded zPREDICTA?
zPREDICTA was founded by Mukti Parikh.
What does zPREDICTA do?
Patient-derived 3D tissue reconstruction models for preclinical…
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of zPREDICTA's application, and every other YC batch, is in YC Insights.
More YC startups like zPREDICTA
